Janus Henderson Investors US’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Janus Henderson Investors US's NVS Position: Q1 2017 in Review
Janus Henderson Investors US increased its Novartis (NVS) stake by 34,404% in Q1 2017, buying an estimated $130M and bringing the position to 1,963,955 shares worth $131M. The position accounts for 0.11% of the portfolio, ranked #241.
Janus Henderson Investors US first reported a position in NVS in Q4 2014 and has held it in 10 quarters since. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.
- Janus Henderson Investors US held 1,963,955 shares of Novartis worth $131M as of Q1 2017.
- Janus Henderson Investors US bought 1,958,263 Novartis shares in Q1 2017, an estimated $130M.
- Novartis made up 0.11% of Janus Henderson Investors US's portfolio in Q1 2017, its #241 holding.
- Janus Henderson Investors US first reported a position in Novartis in Q4 2014 and has held it in 10 quarters since.
- 910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.